Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Sale of 39,341 REPL shares, $510.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Replimune Group, Inc. (REPL) | Sale | 39,341 | $510.3K |
| Jul 1, 2026 | Revolution Medicines, Inc. (RVMD) | Exercise/Conversion | 2,955 | $110.9K |
| Jun 23, 2026 | Revolution Medicines, Inc. (RVMD) | Grant/Award | 1,191 | n/a |
| May 20, 2026 | Replimune Group, Inc. (REPL) | Sale | 37,324 | $189.6K |
| Apr 8, 2026 | Replimune Group, Inc. (REPL) | Grant/Award | 251,240 | n/a |
| Dec 19, 2025 | Replimune Group, Inc. (REPL) | Grant/Award | 200,000 | n/a |
| Dec 4, 2025 | Replimune Group, Inc. (REPL) | Sale | 10,000 | $111.3K |
| Jun 30, 2025 | Revolution Medicines, Inc. (RVMD) | Grant/Award | 3,142 | n/a |
| May 23, 2025 | Replimune Group, Inc. (REPL) | Sale | 25,105 | $202.3K |
| Apr 4, 2025 | Replimune Group, Inc. (REPL) | Grant/Award | 166,667 | n/a |